Wang D F, Chen S D, Zhu G M, Gong W D
Department of Radiotherapy, Yixing Tumor Hospital, Yixing Jiangsu Province 214206, China.
Department of Surgery, Yixing Tumor Hospital, Yixing Jiangsu Province 214206, China.
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):238-240. doi: 10.3760/cma.j.issn.1007-3418.2018.03.013.
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China with high morbidity and mortality, and its mortality rate is only lower than that of gastric cancer. It poses a serious threat to patients' life, which needs to be given special concerns by clinicians and patients for active implementation of effective treatment methods. Generally, major operation is the mainstay of management. Radiotherapy has gained its popularity when diagnosed have no indications for surgical therapy. An effective radiotherapy plans promote the remission of hepatocellular carcinoma to improve patients condition, prognosis, and survival rate. Therefore, we conducted this study to know the research progress of radiotherapy for hepatocellular carcinoma.
肝细胞癌（HCC）是中国最常见的恶性肿瘤之一，发病率和死亡率都很高，其死亡率仅次于胃癌。它对患者的生命构成严重威胁，临床医生和患者都需要特别关注，积极实施有效的治疗方法。一般来说，大手术是主要的治疗手段。当诊断出没有手术治疗指征时，放射治疗就开始受到青睐。有效的放射治疗方案可促进肝细胞癌的缓解，改善患者的病情、预后和生存率。因此，我们开展了这项研究，以了解肝细胞癌放射治疗的研究进展。
